iPUMP

iPump was an Israeli medical device company focused on developing innovative insulin delivery systems for patients with diabetes. The company's primary product was a patch-based insulin pump designed to provide a more discreet and convenient alternative to traditional tubed infusion pumps. By integrating microfluidic technology with user-friendly design, iPump aimed to improve glycemic control and quality of life for individuals requiring continuous subcutaneous insulin infusion. The company was eventually acquired by Tandem Diabetes Care, which integrated iPump's intellectual property and patch pump technology into its own product development pipeline.